Pioglitazone

From Proteopedia
Revision as of 07:21, 11 November 2010 by David Canner (talk | contribs)
Jump to navigationJump to search

Rosuvastatin, also known as Crestor

Drag the structure with the mouse to rotate

Better Known as: Actos

  • Marketed By: Takeda Pharmaceuticals
  • Major Indication: Hypoglycemia & Type 2 Diabetes
  • Drug Class: PPAR-γ Activator - Thiazolidinedione (Glitazones)
  • Date of FDA Approval (Patent Expiration): 1999 (2011)
  • 2009 Sales: $2.4 Billion [1]
  • Why You Should Care: It is the best selling drug to treat Diabetes and is the 10th best selling drug in the United States.
  • The following is a list of Pharmacokinetic Parameters. See: Pharmaceutical Drugs for more information

Mechanism of Action

Pharmacokinetics

Glitazone Comparison
Parameter Pioglitazone (Actos) Rosiglitazone (Avandia)
Tmax (hr)
Cmax (ng/ml)
Bioavailability (%)
Protein Binding (%) 99 99
T1/2 (hr) 3-7 3-4
AUC (ng/ml/hr)
IC50 (nM)
Equivalent Dosage (mg)
Metabolism Hepatic
(CYP2C8)
Hepatic
(CYP2C8)

Effectiveness and Side Effects

Effectiveness

Side Effects

Interesting Facts

The Jist

References


Proteopedia Page Contributors and Editors (what is this?)

David Canner, Alexander Berchansky